Covered recipient · General Payments record
SHERESE LATASHA BUNKLEY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,155.99
- Reported across 41 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $511.12 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Phadia US Inc. | $203.69 | 4 |
| Novo Nordisk AS | $115.51 | 2 |
| Abbott Laboratories | $98.06 | 5 |
| Acerta Pharma LLC | $30.99 | 2 |
| ABBVIE INC. | $29.55 | 1 |
| DEXCOM, INC. | $17.29 | 1 |
| Paratek Pharmaceuticals, Inc. | $16.03 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $21.26 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125038168 | CMS |
| Abbott Laboratories | $20.29 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125038170 | CMS |
| Abbott Laboratories | $22.05 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125038172 | CMS |
| Abbott Laboratories | $19.81 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125038174 | CMS |
| Abbott Laboratories | $14.65 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125038176 | CMS |
| ABBVIE INC. | $29.55 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106847318 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.86 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104684947 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.13 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105489075 | CMS |
| Dexcom, Inc. | $17.29 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153386890 | CMS |
| Novo Nordisk Inc | $16.80 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100349858 | CMS |
| Novo Nordisk Inc | $98.71 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100613803 | CMS |
| Paratek Pharmaceuticals, Inc. | $16.03 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113925804 | CMS |
| Phadia US Inc. | $77.54 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067586504 | CMS |
| Phadia US Inc. | $12.50 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067586506 | CMS |
| Phadia US Inc. | $88.00 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067586508 | CMS |
| Phadia US Inc. | $25.65 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067586510 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.